Clinical Efficacy of Rifampicin Nanoparticle Local Delivery in Post-Surgical Wound Infections Caused by Resistant Bacteria. Link Medical Journal, [S. l.], v. 3, n. 2, p. 1–11, 2025. DOI: 10.61919/xrpzj971. Disponível em: https://linkmjhcr.com/index.php/lmj/article/view/138. Acesso em: 22 may. 2026.